Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

FDA warns against hidden drug in weight loss supplement

The agency found the product contained a controlled substance that was removed from the market in October 2010 for safety reasons.

The FDA is warning consumers not to use, or purchase, Elimulating Weight & Toxin Keeping Beauty, a product promoted for weight loss.

Laboratory analysis confirmed that Elimulating Weight & Toxin Keeping Beauty contains sibutramine. Sibutramine is a controlled substance that was removed from the market in October 2010 for safety reasons.

It was identified by FDA during an examination of international mail shipments.

The product poses a threat to consumers because sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This product may also interact, in life-threatening ways, with other medications a consumer may be taking.

FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO